Acadia Healthcare Company, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $3.15B | $3.11B | $3.01B |
| Medicaid | — | — | $1.03B | $933.2M | $843.0M | $760.3M | $673.4M | $618.3M |
| Medicare | — | — | $418.0M | $374.9M | $326.6M | $317.0M | $288.7M | $279.7M |
| Commercial | — | — | $1.17B | $1.05B | $902.9M | $789.6M | $706.7M | $677.2M |
| Other | — | — | $308.2M | $254.3M | $236.3M | $224.3M | $194.5M | $195.3M |
| UK | — | — | $0 | $0 | $0 | $1.06B | $1.25B | $1.24B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $177.6M | $156.8M | $153.3M | $124.3M | $108.2M | $97.8M | $90.4M | $86.6M |
| Operating Income | $-1.07B | $341.9M | $-25.4M | $374.1M | $275.8M | $183.8M | $585.9M | $593.6M |
| Operating Margin | -32.2% | 10.8% | -0.9% | 14.3% | 11.9% | 5.8% | 18.8% | 19.7% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-1.07B | $341.9M | $-25.4M | $374.1M | $275.8M | $183.8M | $78.4M | $67.4M |
| Income Tax Expense | $26.0M | $77.4M | $-9.7M | $94.1M | $67.6M | $40.6M | $25.1M | $9.9M |
| Net Income | $-1.10B | $255.6M | $-21.7M | $273.1M | $190.6M | $-672.1M | $108.9M | $-175.8M |
| Net Margin | -33.3% | 8.1% | -0.7% | 10.5% | 8.3% | -21.3% | 3.5% | -5.8% |
| EPS (Basic) | $-12.16 | $2.79 | $-0.24 | $3.05 | $2.15 | $-7.65 | $1.24 | $-2.01 |
| EPS (Diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 |
| Shares Outstanding (Basic) | 90.7M | 91.6M | 90.9M | 89.7M | 88.8M | 87.9M | 87.6M | 87.3M |
| Shares Outstanding (Diluted) | 90.7M | 92.1M | 90.9M | 91.6M | 90.8M | 88.6M | 87.8M | 87.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |